TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1514334

Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine combined with 0.05 mg.kg‐1 meperidine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine combined with 0.1 mg.kg‐1 meperidine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine combined with 0.2 mg.kg‐1 meperidine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine combined with 0.3 mg.kg‐1 meperidine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine combined with 0.4 mg.kg‐1 meperidine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine combined with 0.5 mg.kg‐1 meperidine
Number of subjects: 21

Group type: COMPARATOR
Intervention: 0.5% hyperbaric bupivacaine alone
Number of subjects: 21
Study: 6441351

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control (no lithium carbonate)
Number of subjects: 51
Study: 31287240

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 2809

Group type: EXPERIMENTAL
Intervention: Depression in women
Number of subjects: 2809

Group type: EXPERIMENTAL
Intervention: Depression in younger people
Number of subjects: 2809

Group type: EXPERIMENTAL
Intervention: Depression in obese people (BMI ≥30 kg/m2)
Number of subjects: 2809

Group type: EXPERIMENTAL
Intervention: Positive depression and obesity (BMI ≥30 kg/m2)
Number of subjects: 2809
Study: 30334943

Group type: EXPERIMENTAL
Intervention: 260-cm Amplatz Super Stiff guidewire
Number of subjects: 500

Group type: COMPARATOR
Intervention: 150-cm Emerald guidewire standard J‐tip
Number of subjects: 500

Group type: COMPARATOR
Intervention: 150-cm Radifocus guidewire M
Number of subjects: 500
Study: 27128199

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir pellets
Number of subjects: 77

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir syrups
Number of subjects: 77

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir tablets
Number of subjects: 77
Study: 24384831

Group type: EXPERIMENTAL
Intervention: Fibrin glue (Tissucol)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Bovine serum albumin glutaraldehyde surgical adhesive (BioGlue)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both groups (Tissucol and BioGlue)
Number of subjects: 23
Study: 23244011

Group type: EXPERIMENTAL
Intervention: Supportive psychodynamic psychotherapy (SPP) in addition to treatment as usual (TaU)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Treatment as usual (TaU)
Number of subjects: 269
Study: 21146658

Group type: EXPERIMENTAL
Intervention: Discharge antiplatelet therapy (AT)
Number of subjects: 8582

Group type: COMPARATOR
Intervention: No discharge antiplatelet therapy (AT)
Number of subjects: 8582

Group type: EXPERIMENTAL
Intervention: Discharge monotherapy
Number of subjects: 8582

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention
Number of subjects: 8582

Group type: COMPARATOR
Intervention: No percutaneous coronary intervention
Number of subjects: 8582
Study: 18162245

Group type: EXPERIMENTAL
Intervention: Pentavalent rotavirus vaccine (PRV)
Number of subjects: 71799

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71799
Study: 15761435

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.1%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 12389066

Group type: EXPERIMENTAL
Intervention: Levosimendan (2 mg i.v.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Levosimendan (2 mg i.v.) with carvedilol (25 mg orally, twice daily for 7-9 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Levosimendan with carvedilol
Number of subjects: 12
Study: 10335933

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, methotrexate and 5‐fluorouracil (CMF)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: CMF and tamoxifen (TAM)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: TAM alone
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: CMF and TAM
Number of subjects: 41
Study: 7488393

Group type: EXPERIMENTAL
Intervention: 2% Salicylic Acid (SA) for 6 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% Salicylic Acid (SA) for 3 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10% Urea for 3 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10% Urea for 6 hours
Number of subjects: 0
Study: 1955741

Group type: COMPARATOR
Intervention: Metoclopramide (MCP)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Metoclopramide (MCP) + Diphenhydramine
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Number of subjects: 91
Study: 7078288

Group type: EXPERIMENTAL
Intervention: Price-information group (received test order forms with prices of diagnostic tests printed)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (received test order forms with no prices indicated)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Price-information group
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study: 30150003

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (A‐tDCS) 1 mA
Number of subjects: 74

Group type: COMPARATOR
Intervention: Sham tDCS (S‐tDCS)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: A‐tDCS
Number of subjects: 74
Study: 26878875

Group type: EXPERIMENTAL
Intervention: SIT (specific immunotherapy)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (no specific immunotherapy)
Number of subjects: 35
Study: 25896265

Group type: EXPERIMENTAL
Intervention: Survivorship Care Plan (SCP)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: SCP
Number of subjects: 408
Study: 22963921

Group type: EXPERIMENTAL
Intervention: Public Health Nursing (PHN) intervention
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Recession exposure
Number of subjects: 432

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 432
Study: 20628237

Group type: EXPERIMENTAL
Intervention: letrozole (2.5 mg/day)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: oxandrolone (2.5 mg/day)
Number of subjects: 91

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 91
Study: 18381709

Group type: EXPERIMENTAL
Intervention: Pediatric antidepressant treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalizability judgments
Number of subjects: 0
Study: 16374149

Group type: EXPERIMENTAL
Intervention: 12 mL/kg predicted body weight tidal volume group
Number of subjects: 861

Group type: COMPARATOR
Intervention: 6 mL/kg predicted body weight tidal volume group
Number of subjects: 861
Study: 15522044

Group type: EXPERIMENTAL
Intervention: Perometer
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water volumeter
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 20
Study: 10894864

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1,000 mg/m² on days 1, 8, and 15 and cisplatin 100 mg/m² on day 2, every 4 weeks (induction chemotherapy)
Number of subjects: 47
Study: 9373482

Group type: EXPERIMENTAL
Intervention: Hyaluronidase group (150 IU/ml hyaluronidase in anaesthetic solution)
Number of subjects: 92
Study: 1606337

Group type: EXPERIMENTAL
Intervention: Total Nutrient Admixtures (TNA)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Piggyback (PB) administration of lipids
Number of subjects: 96
Study: 4017309

Group type: EXPERIMENTAL
Intervention: Plasmapheresis
Number of subjects: 18

Group type: COMPARATOR
Intervention: Total lymphoid irradiation
Number of subjects: 18
Study: 3661391

Group type: COMPARATOR
Intervention: Sex hormone levels (total and free testosterone, total and free estradiol, androstenedione, estrone) measured in cases and controls.
Number of subjects: 163

Group type: COMPARATOR
Intervention: Controlling for other cardiovascular risk factors.
Number of subjects: 163
Study: 29443399

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous soybean oil (LOW)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard-dose intravenous soybean oil (CON)
Number of subjects: 30
Study: 26502000

Group type: COMPARATOR
Intervention: Smoking abstinence for 7 years in former smokers (control arm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking abstinence for 15 years combined with LDCT screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current smokers
Number of subjects: 0
Study: 24695927

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 240

Group type: COMPARATOR
Intervention: Vitamin C (placebo)
Number of subjects: 240
Study: 22177579

Group type: EXPERIMENTAL
Intervention: HPV DNA and cytology co-testing
Number of subjects: 22420

Group type: COMPARATOR
Intervention: Cytology testing alone
Number of subjects: 22420
Study: 19938977

Group type: EXPERIMENTAL
Intervention: zidovudine-lamivudine plus Nevirapine
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: zidovudine-lamivudine plus Abacavir
Number of subjects: 600
Study: 19039919

Group type: EXPERIMENTAL
Intervention: Professional oral hygiene treatment including plaque and calculus removal, root planing, motivation and instruction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (only periodontal status recorded)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Professional oral hygiene treatment
Number of subjects: 80
Study: 15866609

Group type: EXPERIMENTAL
Intervention: Microdose GnRH agonist protocol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Ganirelix acetate (GnRH antagonist protocol)
Number of subjects: 48
Study: 12766692

Group type: EXPERIMENTAL
Intervention: EX/RP alone
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: EX/RP with medication
Number of subjects: 62

Group type: COMPARATOR
Intervention: Serotonergic medications (fluvoxamine or clomipramine)
Number of subjects: 62
Study: 10693877

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg once daily
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg once daily
Number of subjects: 775

Group type: COMPARATOR
Intervention: Ibuprofen 800 mg three times daily
Number of subjects: 775

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 775
Study: 9113011

Group type: EXPERIMENTAL
Intervention: ICCE with an ACIOL in their first operated eye
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Standard surgery - ICCE with aphakic correction
Number of subjects: 2000
Study: 8018887

Group type: EXPERIMENTAL
Intervention: Mammography screening (not specified dosage or duration)
Number of subjects: 1367

Group type: COMPARATOR
Intervention: No autopsy
Number of subjects: 1367
Study: 3804539

Group type: EXPERIMENTAL
Intervention: Smoking two cigarettes
Number of subjects: 8
Study: 31426623

Group type: EXPERIMENTAL
Intervention: Baska Mask
Number of subjects: 97

Group type: COMPARATOR
Intervention: i-gel
Number of subjects: 97
Study: 29235571

Group type: EXPERIMENTAL
Intervention: High CAIX expression
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Hypoxia-inducible factor-1α
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: GLUT1
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Carbonic anhydrase IX (CAIX)
Number of subjects: 203
Study: 27775810

Group type: EXPERIMENTAL
Intervention: Humanized nursing combined with wet healing therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional method of treatment for pressure ulcer
Number of subjects: 50
Study: 24589954

Group type: EXPERIMENTAL
Intervention: Oral antibiotic therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intramuscular antibiotic therapy
Number of subjects: 24
Study: 23078434

Group type: EXPERIMENTAL
Intervention: Modified introducer method (Group II)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Pull method (Group I)
Number of subjects: 62
Study: 19906790

Group type: EXPERIMENTAL
Intervention: Eucaloric diet (EU; approximately 1800 kcal)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet (HYPO; approximately 1300 kcal)
Number of subjects: 23
Study: 18628275

Group type: EXPERIMENTAL
Intervention: OPC-3
Number of subjects: 61
Study: 16185404

Group type: EXPERIMENTAL
Intervention: Enteral feeding of 50 g/L glucose normal saline (GNS) 500 ml per day containing L‐Arg (400 mg/kg.day) for 4 days (Group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Enteral feeding with only 50 g/L GNS 500 ml per day for 4 days (Group C)
Number of subjects: 20
Study: 11822961

Group type: EXPERIMENTAL
Intervention: Preoperative radiochemotherapy (2 cycles of fluorouracil, 4500 rad)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Control group (no preoperative radiochemotherapy)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Preoperative radiochemotherapy
Number of subjects: 226
Study: 11101479

Group type: EXPERIMENTAL
Intervention: Plant sterols from rice bran oil (2.1 g/d)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Triterpene alcohols from sheanut oil (2.6 g/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control margarine based on sunflower oil
Number of subjects: 60
Study: 8646143

Group type: EXPERIMENTAL
Intervention: Active cream containing aminophylline 3%, isosorbide dinitrate 0.25%, and co-dergocrine mesylate 0.05% for one week
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Active cream
Number of subjects: 36
Study: 1550073

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1000 mg Ca/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypertensive control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary calcium intake
Number of subjects: 0
Study: 3004113

Group type: EXPERIMENTAL
Intervention: 25 mg captopril
Number of subjects: 28
Study: 31599653

Group type: EXPERIMENTAL
Intervention: National BMI growth charts for Iranian children and adolescents
Number of subjects: 22718
Study: 31744023

Group type: EXPERIMENTAL
Intervention: Extubation bundle with modified spontaneous breathing trial (SBT) (10 minutes)
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Successfully extubated babies
Number of subjects: 465
Study: 28611098

Group type: EXPERIMENTAL
Intervention: Ticagrelor and eptifibatide bolus
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ticagrelor and eptifibatide bolus with 2-hour infusion
Number of subjects: 70
Study: 25574925

Group type: EXPERIMENTAL
Intervention: Individual-based support
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Individual-based support combined with family reminders
Number of subjects: 150
Study: 23250568

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: L-NMMA (NOS inhibition)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: L-NMMA + ketorolac (combined intervention)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ketorolac (cyclooxygenase inhibition)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ketorolac + L-NMMA (combined intervention)
Number of subjects: 17
Study: 21242235

Group type: EXPERIMENTAL
Intervention: Disease activity score-driven therapy (tight control group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 0
Study: 19619921

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate plus isotonic saline
Number of subjects: 265

Group type: COMPARATOR
Intervention: Isotonic saline alone
Number of subjects: 265
Study: 17016601

Group type: EXPERIMENTAL
Intervention: 5-FU-based adjuvant chemotherapy
Number of subjects: 161
Study: 14504728

Group type: EXPERIMENTAL
Intervention: Standard foam mattress
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inflated mattress
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deflated mattress
Number of subjects: 0

Group type: COMPARATOR
Intervention: Floor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inflated vs Deflated mattress
Number of subjects: 0

Group type: COMPARATOR
Intervention: All surfaces
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bed height
Number of subjects: 0
Study: 10694831

Group type: EXPERIMENTAL
Intervention: Atenolol (50-100 mg)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Trandolapril (2-4 mg)
Number of subjects: 53
Study: 9219787

Group type: EXPERIMENTAL
Intervention: Combined therapy with 5-ASA tablets 1.6 g/day and 5-ASA enemas 4 g/100 ml twice weekly
Number of subjects: 69

Group type: COMPARATOR
Intervention: Oral therapy with 5-ASA tablets 1.6 g/day and placebo enemas/twice weekly
Number of subjects: 69
Study: 8484646

Group type: COMPARATOR
Intervention: PEEP 0 cm H2O
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: PEEP 3 cm H2O
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: PEEP 6 cm H2O
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: PEEP 9 cm H2O
Number of subjects: 9
Study: 3304850

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oxygen supplementation
Number of subjects: 40
Study: 28956697

Group type: EXPERIMENTAL
Intervention: AppleMets (AMS) nutraceutical formulation containing procyanidin B2 from Annurca apples
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 28086890

Group type: EXPERIMENTAL
Intervention: HEYMAN intervention (n=26)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Waitlist control (n=24)
Number of subjects: 50
Study: 24366914

Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy (NOT) at 3 L/min
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Acetazolamide (2 × 250 mg tablets)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (sham-NOT/placebo tablets)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy (NOT)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 23
Study: 24187321

Group type: EXPERIMENTAL
Intervention: Bilateral mirror image with symmetric movements of both arms
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Unilateral movement of the affected arm
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Standard care provided by a licensed physical therapist
Number of subjects: 5
Study: 20846271

Group type: EXPERIMENTAL
Intervention: Yoga therapy
Number of subjects: 66

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 66

Group type: COMPARATOR
Intervention: Waitlist group
Number of subjects: 66
Study: 18284860

Group type: EXPERIMENTAL
Intervention: Intranasal amphotericin B (AMB) irrigation (20 mg of AMB in 500 mL of normal saline) for 4 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (yellowish dye in 500 mL of normal saline) for 4 weeks
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Intranasal amphotericin B (AMB) irrigation
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Intranasal amphotericin B (AMB) irrigation and Placebo
Number of subjects: 70
Study: 16531113

Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Ganciclovir
Number of subjects: 106

Group type: COMPARATOR
Intervention: CMV disease
Number of subjects: 106

Group type: COMPARATOR
Intervention: Asymptomatic CMV infection
Number of subjects: 106
Study: 14739732

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 335

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 335
Study: 11195235

Group type: EXPERIMENTAL
Intervention: Budesonide (Pulmicort) 500 microg bid
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Budesonide (Pulmicort)
Number of subjects: 30
Study: 9104516

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.10% and 1 mg.ml‐1 meperidine (0.10% group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.05% and 1 mg.ml‐1 meperidine (0.05% group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1 mg.ml‐1 meperidine (0% group)
Number of subjects: 60
Study: 8026249

Group type: EXPERIMENTAL
Intervention: 1 mg/kg erythromycin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 3 mg/kg erythromycin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Erythromycin (1 mg/kg)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Erythromycin (3 mg/kg)
Number of subjects: 35
Study: 2784233

Group type: EXPERIMENTAL
Intervention: Dentifrice containing 250 ppm fluoride
Number of subjects: 1161

Group type: COMPARATOR
Intervention: 1000 ppm sodium fluoride and MFP formulations
Number of subjects: 1161

Group type: EXPERIMENTAL
Intervention: Anticalculus agents (HEBP and AHBP)
Number of subjects: 1161
Study: 1055858

Group type: EXPERIMENTAL
Intervention: Craniospinal irradiation or cranial irradiation combined with intrathecal methotrexate
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Prophylactic craniospinal irradiation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (irradiation to parts of the body other than the cranium)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not receiving prophylactic craniospinal irradiation)
Number of subjects: 45
Study: 31508924

Group type: EXPERIMENTAL
Intervention: HIFU hemi-ablation and concomitant short-term androgen deprivation therapy (ADT)
Number of subjects: 20
Study: 28370340

Group type: EXPERIMENTAL
Intervention: P2B001 (0.6 mg pramipexole/0.75 mg rasagiline)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: P2B001 (0.3 mg pramipexole/0.75 mg rasagiline)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Responder analysis for P2B001 (0.6/0.75 mg)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Responder analysis for P2B001 (0.3/0.75 mg)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 25939584

Group type: EXPERIMENTAL
Intervention: Extended stroke rehabilitation service for 18 months following completion of ESD.
Number of subjects: 510

Group type: COMPARATOR
Intervention: Usual stroke care post-ESD (control group).
Number of subjects: 510
Study: 24671750

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 13
Study: 22962411

Group type: EXPERIMENTAL
Intervention: Heme iron polypeptide (HIP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ferrous sulphate
Number of subjects: 62
Study: 19574871

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided supraclavicular block (SCB)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided infraclavicular block (ICB)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided axillary block (AXB)
Number of subjects: 120